Fundraising Fox
/Companies
Sign in

Ceres Nanosciences

Manassas, US · Founded 2008 · Delaware corporation · 34 employees on LinkedIn · 4 known investors

Find your way into Ceres Nanosciences

Sign up to see every warm intro you have to Ceres Nanosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ceres Nanosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Ceres Nanosciences develops Nanotrap particle technology, a magnetic hydrogel used to capture, concentrate, and preserve low-abundance analytes such as pathogens, proteins, and cell-free biomarkers from complex biological and environmental samples. Its products support sample preparation for molecular, proteomic, and culture-based workflows including PCR, sequencing, mass spectrometry, liquid biopsy, and wastewater surveillance.

BiotechMedical DevicesNew Materials

Founders & leadership

Ceres Nanosciences was founded in 2008 by Ross Dunlap and Emanuel Petricoin III.

RDRoss Dunlap
Ross DunlapFounder and CEO / Chief Executive OfficerThe company develops Nanotrap particle technology, a magnetic hydrogel used to capture and concentrate low-abundance analytes from biological and environmental samples for molecular, proteomic, and culture-based workflows.
EPEmanuel Petricoin III
Emanuel Petricoin IIICo-founder
TD
Thomas DunlapSecretary

Board

TM
Tom MillerBoard director
SG
Scott GazelleBoard director

Investors · 4

Also in the syndicate · 4

Bay Area Lyme FoundationGreyBird VenturesPactolus VenturesUniversity of Virginia LVG Seed Fund

Funding

SEC filings, press & company announcements

$8M disclosed across 2 of 3 rounds · 2017–2022

  • Undisclosed amountSeries AMay 2018

    Bay Area Lyme Foundation, GreyBird Ventures, Pactolus Ventures, University of Virginia LVG Seed Fund

    Source ↗
▶$5MraisedSep 2022 · 1 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Ross DunlapExecutive Officer, Director
  • Ian WrightDirector
  • Scott GazelleDirector
  • Tom MillerDirector
  • Emanuel PetricoinDirector
Amount sold
$5M
Minimum investment
$5M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$3MraisedFeb 2017 · 1 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Tom MillerDirector
  • Scott GazelleDirector
  • Ross DunlapExecutive Officer, Director
  • Thomas DunlapExecutive Officer
  • Emanuel Petricoin IIIDirector
Offering amount
$9M
Amount sold
$3M
Minimum investment
$100K
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

GrailGRAIL develops the Galleri blood test for multi-cancer early detection using next-generation sequencing and machine learning to screen for multiple deadly cancer types before symptoms appear. The test is offered by prescription in the United States and through partnerships with healthcare systems, insurance carriers, and diagnostic platforms.

Companies working in the same space as Ceres Nanosciences.

Non-dilutive funding · 7 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$387.3K
Centers for Disease Control and Prevention (CDC)Centers for Disease Control and PreventionPhase I2020$243.5K
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$224.8K
Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects AgencyPhase II2016$1.7M
Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects AgencyPhase ISTTR2013$99.8K
Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects AgencyPhase II2012$999.7K
Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects AgencyPhase I2012$149.8K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Ceres Nanosciences do?
Ceres Nanosciences develops Nanotrap particle technology, a magnetic hydrogel used to capture, concentrate, and preserve low-abundance analytes such as pathogens, proteins, and cell-free biomarkers from complex biological and environmental samples. Its products support sample preparation for molecular, proteomic, and culture-based workflows including PCR, sequencing, mass spectrometry, liquid biopsy, and wastewater surveillance.
Who founded Ceres Nanosciences?
Ceres Nanosciences was founded by Ross Dunlap, Emanuel Petricoin III in 2008.
How much funding has Ceres Nanosciences raised?
Ceres Nanosciences has disclosed $8M raised across 2 of its 3 known rounds.
Where is Ceres Nanosciences headquartered?
Ceres Nanosciences is headquartered in Manassas, US.